302 related articles for article (PubMed ID: 36993958)
21. Identification of the Expression of TIE1 and Its Mediated Immunosuppression in Gastric Cancer.
Gong Z; Zheng Q; Li B; Wang H; Chen H; Lin S
J Cancer; 2024; 15(10):2994-3009. PubMed ID: 38706903
[No Abstract] [Full Text] [Related]
22. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
23. Testing lncRNAs signature as clinical stage-related prognostic markers in gastric cancer progression using TCGA database.
Beeraka NM; Gu H; Xue N; Liu Y; Yu H; Liu J; Chen K; Nikolenko VN; Fan R
Exp Biol Med (Maywood); 2022 Apr; 247(8):658-671. PubMed ID: 35068210
[TBL] [Abstract][Full Text] [Related]
24. Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers.
Tai P; Wang Z; Chen X; Chen A; Gong L; Cheng Y; Cao K
Cancer Med; 2023 May; 12(10):11941-11959. PubMed ID: 36205192
[TBL] [Abstract][Full Text] [Related]
25. High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.
Li H; Su Q; Li B; Lan L; Wang C; Li W; Wang G; Chen W; He Y; Zhang C
J Cell Mol Med; 2020 Apr; 24(8):4452-4465. PubMed ID: 32176425
[TBL] [Abstract][Full Text] [Related]
26. LINC00922 promotes deterioration of gastric cancer.
Ge H; Yan Y; Tian F; Guo L; He X; Wang C; Song J; Deng Z
PLoS One; 2022; 17(5):e0267798. PubMed ID: 35511773
[TBL] [Abstract][Full Text] [Related]
27. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
28. ceRNA network construction and comparison of gastric cancer with or without Helicobacter pylori infection.
Liu Y; Zhu J; Ma X; Han S; Xiao D; Jia Y; Wang Y
J Cell Physiol; 2019 May; 234(5):7128-7140. PubMed ID: 30370523
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of lncRNA-miRNA-mRNA networks during osteogenic differentiation of bone marrow mesenchymal stem cells.
Liu J; Yao Y; Huang J; Sun H; Pu Y; Tian M; Zheng M; He H; Li Z
BMC Genomics; 2022 Jun; 23(1):425. PubMed ID: 35672672
[TBL] [Abstract][Full Text] [Related]
30. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E
Front Oncol; 2023; 13():1110207. PubMed ID: 37427102
[TBL] [Abstract][Full Text] [Related]
31. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
32. [Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer].
Li R; Jiang WJ; Jin SL; Zhao RH; Cao XG; Zong H
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):115-121. PubMed ID: 32135645
[No Abstract] [Full Text] [Related]
33. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
34. AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer.
Zeng Y; Zhang X; Li F; Wang Y; Wei M
J Clin Lab Anal; 2022 Jun; 36(6):e24437. PubMed ID: 35478418
[TBL] [Abstract][Full Text] [Related]
35. FHIP1A-DT is a potential novel diagnostic, prognostic, and therapeutic biomarker of colorectal cancer: A pan-cancer analysis.
Yang Y; Xiong Z; Li W; Lin Y; Huang W; Zhang S
Biochem Biophys Res Commun; 2023 Oct; 679():191-204. PubMed ID: 37703762
[TBL] [Abstract][Full Text] [Related]
36. Collagen family genes and related genes might be associated with prognosis of patients with gastric cancer: an integrated bioinformatics analysis and experimental validation.
Weng K; Huang Y; Deng H; Wang R; Luo S; Wu H; Chen J; Long M; Hao W
Transl Cancer Res; 2020 Oct; 9(10):6246-6262. PubMed ID: 35117235
[TBL] [Abstract][Full Text] [Related]
37. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
38. A new risk model based on a 11-m
Lei L; Li N; Yuan P; Liu D
BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
[TBL] [Abstract][Full Text] [Related]
39. The clinical significance and biological function of tropomyosin 4 in colon cancer.
Yang R; Zheng G; Ren D; Chen C; Zeng C; Lu W; Li H
Biomed Pharmacother; 2018 May; 101():1-7. PubMed ID: 29455030
[TBL] [Abstract][Full Text] [Related]
40. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
Zhang J; Wang K; Hainisayimu T; Li H
Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]